Neurocognitive and Self-efficacy Benefits of Cognitive Remediation in Schizophrenia: A Randomized Controlled Trial
Overview
Psychology
Authors
Affiliations
Objectives: The aim of this study was to evaluate the impact of computer-assisted "drill-and-strategy" cognitive remediation (CR) for community-dwelling individuals with schizophrenia on cognition, everyday self-efficacy, and independent living skills.
Methods: Fifty-six people with schizophrenia or schizoaffective disorder were randomized into CR or computer game (CG) playing (control), and offered twenty 1-hr individual sessions in a group setting over 10 weeks. Measures of cognition, psychopathology, self-efficacy, quality of life, and independent living skills were conducted at baseline, end-group and 3 months following intervention completion.
Results: Forty-three participants completed at least 10 sessions and the end-group assessment. Linear mixed-effect analyses among completers demonstrated a significant interaction effect for global cognition favoring CR (p=.028). CR-related cognitive improvement was sustained at 3-months follow-up. At end-group, 17 (77%) CR completers showed a reliable improvement in at least one cognitive domain. A significant time effect was evident for self-efficacy (p=.028) with both groups improving over time, but no significant interaction effect was observed. No significant effects were found for other study outcomes, including the functional measure.
Conclusions: Computer-assisted drill-and-strategy CR in schizophrenia improved cognitive test performance, while participation in both CR and CG playing promoted enhancements in everyday self-efficacy. Changes in independent living skills did not appear to result from CR, however. Adjunctive psychosocial rehabilitation is likely necessary for improvements in real-world community functioning to be achieved. (JINS, 2018, 24, 549-562).
"Food for Thought": Improving Cognition in People With Schizophrenia.
Wykes T Psychiatry Investig. 2024; 21(8):803-809.
PMID: 39111751 PMC: 11321879. DOI: 10.30773/pi.2023.0320.
Wykes T, Bowie C, Cella M Schizophr Bull. 2024; 50(5):993-1005.
PMID: 38780191 PMC: 11349022. DOI: 10.1093/schbul/sbae075.
Oie M, Haugen I, Stubberud J, Oie M Front Psychol. 2024; 15:1320986.
PMID: 38515967 PMC: 10955763. DOI: 10.3389/fpsyg.2024.1320986.
Morales-Pillado C, Fernandez-Castilla B, Sanchez-Gutierrez T, Gonzalez-Fraile E, Barbeito S, Calvo A Psychol Med. 2022; 53(13):6304-6315.
PMID: 36472150 PMC: 10520607. DOI: 10.1017/S0033291722003610.
Altman R, Tan E, Rossell S Can J Psychiatry. 2022; 68(3):139-151.
PMID: 36448242 PMC: 9974655. DOI: 10.1177/07067437221129073.